Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...
Acute interstitial nephritis (AIN) is often caused by an allergic reaction to a medication; it can also be associated with autoimmune conditions and with various infections. Most causes of AIN ...